The firm is examining the proposed sale of Cross Country Healthcare, Inc. (CCRN) to KL Criss Cross Intermediate, LLC, which offers shareholders $13.25 per share. The vote for this transaction is set for July 16, 2026. Simultaneously, Monteverde is reviewing the merger between Equitable Holdings, Inc. (EQH) and Corebridge Financial, Inc., where Equitable investors would retain a 49% stake in the combined entity, with a vote scheduled for July 30.

Additional scrutiny is directed at Axalta Coating Systems Ltd. (AXTA) regarding its sale to Akzo Nobel N.V. Under that agreement, Axalta shareholders are slated to receive 0.6539 shares of AkzoNobel stock for each share held, with a vote on August 5. Finally, the firm is investigating the sale of Citizens National Corporation (CZNL) to Peoples Bancorp, Inc., a deal involving 2.10 shares of Peoples stock plus $8.00 in cash per share, ahead of an August 6 vote. Investors seeking further details on these investigations or legal guidance may contact the firm at its Empire State Building headquarters.